Pediatric BMT Program

THURSDAY – FEBRUARY 14

A parallel track of sessions on hematopoietic stem cell transplants for children and adolescents will be held throughout the day on Thursday, February 14, at the 2008 BMT Tandem Meetings in San Diego.  The programs are coordinated by the ASBMT Pediatric BMT Special Interest Group and the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

10:30 am
Immunotherapy for Pediatric Cancer
Laurence J.N. Cooper, MD, Chair
   ■ Cell Therapies in High-Risk Pediatric Malignancies
         Stephen A. Grupp, MD, PhD
   ■ Incorporation of Therapeutic Monoclonal Antibody into Childhood Cancer Trials
         Paul M. Sondel, MD, PhD
   ■ Harnessing the (Natural) Killer during Transplantation
         Michael R. Verneris, MD

12:15 pm
Pediatric Session Symposium and Luncheon
Carmen Bonfim, MD, and Richard Kadota, MD, Co-Chairs
   ■ Cord Blood Transplantation in Japan
         Shunichi Kato, MD, PhD
   ■ Hematopoietic Stem Cell Transplantation for Fanconi's Anemia
         Mouhab Ayas, MD 
   ■ Pediatric Transplantation in Eastern Europe
         Jacek Wachiwiak, MD, PhD
   ■ Current Status and Future Trends of Stem Cell Transplantation for Thalassemia in Thailand
         Preeda Vanichsetakul, MD

1:30 pm
Alternative Allogeneic Donor Sources for Transplantation for Childhood Diseases 
Mitchell S. Cairo, MD, Chair
   ■ Unrelated Donor Transplants for Pediatric Non-Malignant Disease, including
      Hemoglobinopathies
         Vanderson Rocha, MD
   ■ Haploidentical Transplants for Childhood Hematologic Malignancies
         Gregory A. Hale, MD
   ■ The Influence of Cell Dose and HLA Match for Unrelated Cord Blood Transplants
         John E. Wagner, MD 

1:30 pm
Pediatric Perspectives on Immune Reconstitution and Vaccination
   ■ Revaccination after Allogeneic Stem Cell Transplantation
         Trudy N. Small, MD
   ■ Improved Immune Reconstitution and Low Mortality after Haploidentical Transplantation
      Using Reduced-Intensity Conditioning and CD3/CD19 Depletion
         Rupert Handgretinger, MD, PhD
   ■ Immune Reconstitution after Unrelated Cord Blood Transplantation:  The Expected and
      the Unique
         Paul Szabolcs, MD

3:00 pm
Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency Diseases
   ■ Issues of Transplantation for SCID
         Morton J. Cowan, MD
   ■ Late Immunological and Clinical Outcome for a Large Cohort of Transplanted SCID Patients
         Bénédicte Neven, MD
   ■ Newborn Screening for SCID
         Jennifer M. Puck, MD
   ■ To Ablate or Not To Ablate: That Is the Question  (Panel Discussion)
         Trudy M. Small, MD; Luigi D. Notarangelo, MD; Naynesh Kamani, MD; Neena Kapoor, MD; 
         and Alexandra H. Filipovich, MD

3:00 pm
Late Effects of Transplantation in Children and Adolescents
   ■ Oral and Dental Late Effects after Pediatric Stem Cell Transplantation
         Göran Dahllöf, DDS, PhD
   ■ The Kidney after Hematopoietic Cell Transplant
         Sangeeta Hingorani, MD, MPH
   ■ Evaluation for Late Effects after Pediatric Hematopoietic Transplantation
         Jean E. Sanders, MD

4:30 pm
Outstanding Pediatric Abstracts
          Michael Pulsipher, MD, Chair

6:00 pm
Pediatric Posters  (Included in Poster Session I)

7:30 pm
Meeting of the Pediatric Blood and Marrow Transplant Consortium (PBMTC)